These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Baroreflex Amplification and Carotid Body Modulation for the Treatment of Resistant Hypertension. Groenland EH; Spiering W Curr Hypertens Rep; 2020 Mar; 22(4):27. PubMed ID: 32166464 [TBL] [Abstract][Full Text] [Related]
31. Long-term effects of baroreflex activation therapy: 2-year follow-up data of the BAT Neo system. Wallbach M; Born E; Kämpfer D; Lüders S; Müller GA; Wachter R; Koziolek MJ Clin Res Cardiol; 2020 Apr; 109(4):513-522. PubMed ID: 31388741 [TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of baroreflex activation therapy for heart failure with reduced ejection fraction: a rapid systematic review. Schmidt R; Rodrigues CG; Schmidt KH; Irigoyen MCC ESC Heart Fail; 2020 Feb; 7(1):3-14. PubMed ID: 31965746 [TBL] [Abstract][Full Text] [Related]
33. Resistant hypertension: baroreflex stimulation as a new tool. Menne J; Jordan J; Linnenweber-Held S; Haller H Nephrol Dial Transplant; 2013 Feb; 28(2):288-95. PubMed ID: 23223217 [TBL] [Abstract][Full Text] [Related]
34. Baroreflex Activation Therapy in Heart Failure With Reduced Ejection Fraction: Available Data and Future Perspective. Halbach M; Fritz T; Madershahian N; Pfister R; Reuter H Curr Heart Fail Rep; 2016 Apr; 13(2):71-6. PubMed ID: 26879389 [TBL] [Abstract][Full Text] [Related]
35. Cardiac Contractility Modulation and Baroreflex Activation Therapy in Heart Failure Patients. Mann JA; Abraham WT Curr Heart Fail Rep; 2019 Feb; 16(1):38-46. PubMed ID: 30762177 [TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of baroreflex activation therapy for treatment of resistant hypertension: a systematic review and meta-analysis. Chunbin W; Fu S; Jing H Clin Exp Hypertens; 2018; 40(6):501-508. PubMed ID: 29624472 [TBL] [Abstract][Full Text] [Related]